Ares Management Corporation

Based on a comprehensive review, ARES presents significant challenges across all key areas, making it a high-risk proposition at its current price.

Technical Analysis shows the stock is in a pronounced downtrend, trading near 52-week lows with severe underperformance versus the market. While this indicates oversold conditions, it primarily reflects deteriorating investor sentiment and a lack of positive catalysts. Fundamentals reveal critical weaknesses; despite revenue growth, net income collapsed last quarter, and negative cash flows point to potential liquidity strain, overshadowing its low debt level. Valuation metrics are a major red flag, with an exceptionally high forward P/E and negative PEG ratio signaling the market expects sharp earnings decline, making the current price difficult to justify.

Recommendation: Do Not Buy. The combination of negative earnings momentum, severe overvaluation, and high volatility creates an unattractive risk-reward profile. Investors should wait for clear signs of improved profitability and cash flow generation before considering a position. This analysis is for reference only and not investment advice.

RockFlow Model Forecast: Three Scenarios for 2026

Of course. Based on the analysis provided, here is a 12-month outlook for ARES:

12-Month Outlook for ARES

The outlook for ARES over the next 12 months is cautious, with the potential for further downside before stabilization. The key catalyst for any positive movement would be a clear reversal in its earnings trajectory, demonstrating an ability to translate revenue growth into sustainable profitability and positive cash flow. The primary risks remain elevated, including the persistent negative earnings momentum, strained liquidity suggested by negative cash flows, and its severe overvaluation which leaves the stock vulnerable to multiple compression. Given the lack of a clear analyst target and the current bearish technical and fundamental backdrop, a prudent near-term target range would be to test lower support levels, with a rally back towards the $100-$110 range contingent on a significant fundamental improvement that is not yet evident.

Wall Street Consensus

Most Wall Street analysts are optimistic about Ares Management Corporation's 12-month outlook, with consensus target around $112.01, indicating expected upside potential.

Overall, ARES has investment potential but also faces challenges. Here are key factors to weigh before investing.

Overall Assessment

ARES has demonstrated significant underperformance with substantial price declines over recent periods, reflecting heightened investor concerns amid elevated volatility.

Short-term Performance

The stock declined 20.95% over one month and 18.18% over three months, substantially underperforming the market by 23.81% during the latter period. This pronounced weakness suggests deteriorating sentiment or company-specific challenges outweighing broader market conditions.

Current Position

Trading at $118.08, ARES sits just 6.7% above its 52-week low of $110.63, positioning it near oversold territory despite being 39.5% below its 52-week high. The proximity to the lower bound of its yearly range, coupled with a maximum drawdown of 40.56%, indicates potential oversold conditions unless fundamental deterioration persists.

Revenue & Profitability Q4 2025 revenue increased to $1.77 billion (from $1.66 billion in Q3), but profitability deteriorated significantly as the net income ratio collapsed to 3.1% from 17.4% in the prior quarter. This sharp decline was driven by a substantial increase in other expenses, which heavily impacted the bottom line despite solid gross and operating profit margins.

Financial Health The company maintains a very low debt ratio of 2.3% with a strong cash position of $6.78 per share, indicating minimal leverage. However, concerning negative operating and free cash flow per share (-$2.19 and -$2.26 respectively) and a cash flow to debt ratio of -0.72 suggest potential liquidity pressures despite the solid balance sheet.

Operational Efficiency Operational efficiency metrics show challenges with a low return on equity of 0.63% and weak asset turnover of 0.06, indicating suboptimal utilization of assets to generate revenue. The high price-to-earnings ratio of 164.7 further reflects market concerns about the company's current earnings power relative to its valuation.

Based on the PE ratio analysis, ARES appears significantly overvalued. The trailing PE of 26.83 is high, but the forward PE of 164.72 is exceptionally elevated and signals extreme market pessimism about future earnings. This negative outlook is corroborated by a deeply negative PEG ratio of -1.86, which typically indicates that earnings growth is expected to be negative, making the high forward earnings multiple unjustifiable. The extremely high EV/EBITDA of 114.93 further confirms that the company's operational cash flow generation is insufficient to support its current enterprise value.

Direct comparison to industry averages is not possible with the data provided. However, the metrics themselves point to severe overvaluation without needing a benchmark. A forward PE above 160 and an EV/EBITDA near 115 are almost universally considered unsustainable and indicative of a stock price that has far outpaced both its current earnings and its near-term profit potential. The negative PEG ratio solidifies this assessment, suggesting the market is pricing in a substantial earnings decline.

The stock exhibits significant volatility risk, with a Beta of 1.524 indicating it is substantially more volatile than the broader market. This elevated sensitivity is confirmed by the severe maximum drawdown of -40.56% over the past year, highlighting considerable downside potential during market stress.

The absence of short interest suggests minimal immediate pressure from bearish speculation. However, the high volatility inherent in the stock could present liquidity challenges during sharp market moves, as price gaps may become more pronounced.